Bruix J, Gores GJ, Mazzaferro V (2014) Hepatocellular carcinoma: clinical frontiers and perspectives. Gut 63:844–855
Article CAS PubMed Google Scholar
Nababan SHH, Lesmana CRA (2022) Portal hypertension in nonalcoholic fatty liver disease: from pathogenesis to clinical practice. J Clin Transl Hepatol 10:979–985
Article PubMed PubMed Central Google Scholar
Sakiani S, Heller T (2022) Current and investigational drugs in early clinical development for portal hypertension. Front Med (Lausanne) 9:974182
European Association for the Study of the Liver (2018) EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 69:182–236
Liu J, Zhang H, Xia Y, Yang T, Gao Y, Li J et al (2019) Impact of clinically significant portal hypertension on outcomes after partial hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis. HPB (Oxford) 21:1–13
Ishizawa T, Hasegawa K, Aoki T, Takahashi M, Inoue Y, Sano K et al (2008) Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology 134:1908–1916
Oba A, Ishizawa T, Mise Y, Inoue Y, Ito H, Ono Y et al (2019) Possible underestimation of blood loss during laparoscopic hepatectomy. BJS Open 3:336–343
Article CAS PubMed PubMed Central Google Scholar
Takahara T, Wakabayashi G, Beppu T, Aihara A, Hasegawa K, Gotohda N et al (2015) Long-term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi-institutional Japanese study. J Hepato-Bil Pancreat Sci 22:721–727
Ishizawa T, Hasegawa K, Kokudo N, Sano K, Imamura H, Beck Y et al (2009) Risk factors and management of ascites after liver resection to treat hepatocellular carcinoma. Arch Surg 144:46–51
Uchiyama H, Harimoto N, Itoh S, Yoshizaumi T, Ikegami T, Maehara Y (2017) Pleural effusion after hepatectomy for hepatocellular carcinoma: risk factor analyses and its impact on oncological outcomes. World J Surg 41:1089–1099
Zhao Y, Jin Y, Wu Y (2016) Postoperative infectious complications after liver resection for hepatocellular carcinoma. J Cancer Res Ther 12:C268-270
Li YR, Chen JD, Huang J, Wu FX, Jin GZ (2022) Post-hepatectomy liver failure prediction and prevention: development of a nomogram containing postoperative anticoagulants as a risk factor. Ann Hepatol 27:100744
Article CAS PubMed Google Scholar
Imai D, Maeda T, Wang H, Shimagaki T, Sanefuji K, Kayashima H et al (2021) Risk factors for and outcomes of intraoperative blood loss in liver resection for hepatocellular tumors. Am Surg 87:376–383
Molina V, Sampson-Davila J, Ferrer J, Fondevila C, Diaz Del Gobbo R, Calatayud D et al (2018) Benefits of laparoscopic liver resection in patients with hepatocellular carcinoma and portal hypertension: a case-matched study. Surg Endosc 32:2345–2354
Lim C, Osseis M, Lahat E, Doussot A, Sotirov D, Hemery F et al (2019) Safety of laparoscopic hepatectomy in patients with hepatocellular carcinoma and portal hypertension: interim analysis of an open prospective study. Surg Endosc 33:811–820
Zheng J, Feng X, Liang Y, Cai J, Shi Z, Kirih MA et al (2021) Safety and feasibility of laparoscopic liver resection for hepatocellular carcinoma with clinically significant portal hypertension: a propensity score-matched study. Surg Endosc 35:3267–3278
Casellas-Robert M, Lim C, Lopez-Ben S, Llado L, Salloum C, Codina-Font J et al (2020) Laparoscopic liver resection for hepatocellular carcinoma in Child-Pugh A patients with and without portal hypertension: a multicentre study. World J Surg 44:3915–3922
Harada N, Maeda T, Yoshizumi T, Ikeda T, Kayashima H, Ikegami T et al (2016) Laparoscopic liver resection is a feasible treatment for patients with hepatocellular carcinoma and portal hypertension. Anticancer Res 36:3489–3497
Azoulay D, Ramos E, Casellas-Robert M, Salloum C, Llado L, Nadler R et al (2021) Liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension. JHEP Rep 3:100190
Llovet JM, Bru C, Bruix J (1999) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19:329–338
Article CAS PubMed Google Scholar
Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693–699
Article CAS PubMed Google Scholar
Ueno M, Hayami S, Sonomura T, Kawai M, Hirono S, Okada KI et al (2019) Concomitant use of indocyanine green fluorescence imaging and interventional radiology for detection of liver segments during laparoscopic anatomical liver resection: pilot feasibility study. Surg Laparosc Endosc Percutan Tech 29:242–246
Ishizawa T, Gumbs AA, Kokudo N, Gayet B (2012) Laparoscopic segmentectomy of the liver: from segment I to VIII. Ann Surg 256:959–964
Lim C, Ishizawa T, Miyata A, Mise Y, Sakamoto Y, Hasegawa K et al (2016) Surgical indications and procedures for resection of hepatic malignancies confined to segment VII. Ann Surg 263:529–537
Liang X, Zheng J, Xu J, Tao L, Cai J, Liang Y et al (2021) Laparoscopic anatomical portal territory hepatectomy using Glissonean pedicle approach (Takasaki approach) with indocyanine green fluorescence negative staining: how I do it. HPB (Oxford) 23:1392–1399
Hu JX, Dai WD, Miao XY, Zhong DW, Huang SF, Wen Y et al (2009) Anatomic resection of segment VIII of liver for hepatocellular carcinoma in cirrhotic patients based on an intrahepatic Glissonian approach. Surgery 146:854–860
Wada H, Eguchi H, Nagano H, Kubo S, Nakai T, Kaibori M et al (2018) Perioperative allogenic blood transfusion is a poor prognostic factor after hepatocellular carcinoma surgery: a multi-center analysis. Surg Today 48:73–79
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213
Article PubMed PubMed Central Google Scholar
Koch M, Garden OJ, Padbury R, Rahbari NN, Adam R, Capussotti L et al (2011) Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the international study group of liver surgery. Surgery 149:680–688
Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR (1999) Guideline for prevention of surgical site infection, 1999. Hospital infection control practices advisory committee. Infect Control Hosp Epidemiol 1999(20):250–278
Famularo S, Donadon M, Cipriani F, Ardito F, Iaria M, Carissimi F et al (2021) The impact of postoperative ascites on survival after surgery for hepatocellular carcinoma: a national study. J Gastrointest Surg 25:2823–2834
Kubo S, Tsukamoto T, Hirohashi K, Tanaka H, Shuto T, Takemura S et al (2004) Correlation between preoperative serum concentration of type IV collagen 7s domain and hepatic failure following resection of hepatocellular carcinoma. Ann Surg 239:186–193
Article PubMed PubMed Central Google Scholar
Rosenbaum PR, Rubin DB (1984) Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc 79:516–524
Premkumar M, Anand AC (2022) Overview of complications in cirrhosis. J Clin Exp Hepatol 12:1150–1174
Article CAS PubMed PubMed Central Google Scholar
Wang J, Zhang Z, Shang D, Li J, Liu C, Yu P et al (2022) Noninvasively assessed portal hypertension grade predicts post-hepatectomy liver failure in patients with HepatocellCarcinoma: a multicenter study. Front Oncol 12:934870
Article CAS PubMed PubMed Central Google Scholar
Yoshino K, Yoh T, Taura K, Seo S, Ciria R, Briceno-Delgado J (2021) A systematic review of prediction models for post-hepatectomy liver failure in patients undergoing liver surgery. HPB (Oxford) 23:1311–1320
Choi SB, Kim HJ, Song TJ, Ahn HS, Choi SY (2014) Influence of clinically significant portal hypertension on surgical outcomes and survival following hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis. J Hepato-Bil Pancreat Sci 21:639–647
He W, Zeng Q, Zheng Y, Chen M, Shen J, Qiu J et al (2015) The role of clinically significant portal hypertension in hepatic resection for hepatocellular carcinoma patients: a propensity score matching analysis. BMC Cancer 15:263
Article PubMed PubMed Central Google Scholar
Westerkamp AC, Lisman T, Porte RJ (2009) How to minimize blood loss during liver surgery in patients with cirrhosis. HPB (Oxford) 11:453–458
留言 (0)